Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024)

Guided Therapeutics' Dividends Paid - Common history spans 2 years, with the latest figure at $120120.0 for Q1 2024.

  • For Q1 2024, Dividends Paid - Common changed 0.0% year-over-year to $120120.0; the TTM value through Jun 2024 reached $120120.0, up 83.96%, while the annual FY2023 figure was $65296.0, 45.64% down from the prior year.
  • Dividends Paid - Common for Q1 2024 was $120120.0 at Guided Therapeutics, up from -$54824.0 in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $120120.0 in Q1 2023 and bottomed at -$54824.0 in Q2 2023.